Scandi Standard (SCST) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
3 Feb, 2026Executive summary
Achieved strong volume and profit growth in Q2 2024, with EBIT up 5% to SEK 127 million and margin improved to 3.8% from 3.5%, driven by Ready-to-Cook segment performance and efficiency gains.
Net sales declined 2% year-over-year to SEK 3,350 million, mainly due to Ready-to-Eat contract loss and normalization in Ingredients.
Ready-to-Eat showed sequential EBIT recovery but remained below prior year levels due to contract loss and absence of insurance compensation.
Maintained strong operating cash flow and balance sheet, though net cash flow and net debt were impacted by the Jaeren acquisition and dividend payout.
Advanced sustainability initiatives, with improvements in antibiotics usage and animal welfare indicators.
Financial highlights
Q2 2024 EBIT increased 5% to SEK 127 million; EBIT margin rose to 3.8% (up 0.2ppt year-over-year).
Net income for Q2 was SEK 71 million, down 3% year-over-year; H1 net income up 20% to SEK 141 million.
Ready-to-Cook EBIT more than doubled to SEK 98 million, with 2% net sales and 3% volume growth.
Ready-to-Eat EBIT fell to SEK 38 million, impacted by contract loss and lower production; margin at 5.6%.
Dividend of SEK 2.30 per share for 2024, split between May and September payments.
Outlook and guidance
Targeting 5%-7% net sales growth and EBIT margin above 6% by 2027, with Q2 margin at 3.8% showing progress.
Continued profitable growth expected in Ready-to-Cook and gradual EBIT improvement in Ready-to-Eat.
Investment program of SEK 2 billion for 2024-2027 to support growth, efficiency, and sustainability, with SEK 500 million capex in 2024.
Focus on efficiency, product mix, and sustainability to drive future profitability.
Latest events from Scandi Standard
- Q4 profit and sales surged, margins improved, and dividend rose 32% with strong 2026 outlook.SCST
Q4 20255 Feb 2026 - Adjusted EBIT up 18% with margin gains and Lithuanian acquisition boosting future growth.SCST
Q3 202418 Jan 2026 - Sales and EBIT rose, with acquisitions and investments driving future growth.SCST
Q1 202523 Dec 2025 - Record Q4 sales and EBIT, with acquisitions and higher dividend supporting future growth.SCST
Q4 202423 Dec 2025 - Record EBIT and 6% sales growth in Q2, with strong demand and positive Lithuania ramp-up.SCST
Q2 202516 Nov 2025 - Record EBIT and 11% sales growth, led by Ready-to-Cook and new market expansion.SCST
Q3 202523 Oct 2025